Sources | Names Used |
---|---|
CTRPv2 | Repligen 136 |
PharmacoGx | Repligen 136 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KLRF2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | NME9 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | TEX35 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
mRNA | TEX15 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | GATAD2B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | SBDS | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
mRNA | RALGPS2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | UNC50 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | CFL2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |